Adolfo Garcia-Ocaña

Adolfo Garcia-Ocaña

Auto-generated profile, based on publicly available information

Adolfo Garcia-Ocaña

Department of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2014 in Diabetes
Verified
Journal Article
Open access
EBErnesto Bernal-Mizrachi
Ernesto Bernal-Mizrachi
RKRohit N. Kulkarni
Rohit N. Kulkarni
DSDonald K. Scott
Donald K. Scott
FMFranck Mauvais-Jarvis
Franck Mauvais-Jarvis
ASAndrew F. Stewart
Andrew F. Stewart
AGAdolfo Garcia-Ocaña
Adolfo Garcia-Ocaña
Enhancing β-cell proliferation is a major goal for type 1 and type 2 diabetes research. Unraveling the network of β-cell intracellular signaling pathways that promote β-cell replication can provide the tools to address this important task. In a previous Perspectives in Diabetes article, we discussed what was known regarding several important intracellular signaling pathways in rodent β-cells, including the insulin receptor substrate/phosphatidylinositol-3 kinase/Akt (IRS-PI3K-Akt) pathways, glycogen synthase kinase-3 (GSK3) and mammalian target of rapamycin (mTOR) S6 kinase pathways, protein kinase Cζ (PKCζ) pathways, and their downstream cell-cycle molecular targets, and contrasted that ample knowledge to the small amount of complementary data on human β-cell intracellular signaling pathways. In this Perspectives, we summarize additional important information on signaling pathways activated by nutrients, such as glucose; growth factors, such as epidermal growth factor, platelet-derived growth factor, and Wnt; and hormones, such as leptin, estrogen, and progesterone, that are linked to rodent and human β-cell proliferation. With these two Perspectives, we attempt to construct a brief summary of knowledge for β-cell researchers on mitogenic signaling pathways and to emphasize how little is known regarding intracellular events linked to human β-cell replication. This is a critical aspect in the long-term goal of expanding human β-cells for the prevention and/or cure of type 1 and type 2 diabetes.

12 February 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
CACourtney Ackeifi
Courtney Ackeifi
PWPeng Wang
Peng Wang
EKEsra Karakose
Esra Karakose
JFJocelyn E. Manning Fox
Jocelyn E. Manning Fox
BGBryan J. González
Bryan J. González
ASAndrew F. Stewart
Andrew F. Stewart
GLP-1 receptor agonists, widely used to treat diabetes, are converted to human β cell regenerative drugs by adding a DYRK1A inhibitor.

9 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
AAAlexandra Alvarsson
Alexandra Alvarsson
MJMaria Jimenez-Gonzalez
Maria Jimenez-Gonzalez
RLRosemary Li
Rosemary Li
CRCarolina Rosselot
Carolina Rosselot
NTNikolaos Tzavaras
Nikolaos Tzavaras
SSSarah A. Stanley
Sarah A. Stanley
Three-dimensional mapping of pancreatic innervation shows rapid remodeling of islet innervation in mouse and human diabetes.

13 December 2013 in Diabetes
Verified
Journal Article
Open access
PDF file
JAJuan Carlos Alvarez-Perez
Juan Carlos Alvarez-Perez
SESara Ernst
Sara Ernst
CDCem Demirci
Cem Demirci
GCGabriella P. Casinelli
Gabriella P. Casinelli
JMJose Manuel D. Mellado-Gil
Jose Manuel D. Mellado-Gil
AGAdolfo Garcia-Ocaña
Adolfo Garcia-Ocaña
Hepatocyte growth factor (HGF) is a mitogen required for β-cell replication during pregnancy. To determine whether HGF/c-Met signaling is required for β-cell regeneration, we characterized mice with pancreatic deletion of the HGF receptor, c-Met (PancMet KO mice), in two models of reduced β-cell mass and regeneration: multiple low-dose streptozotocin (MLDS) and partial pancreatectomy (Ppx). We also analyzed whether HGF administration could accelerate β-cell regeneration in wild-type (WT) mice after Ppx. Mouse islets obtained 7 days post-Ppx displayed significantly increased c-Met, suggesting a potential role for HGF/c-Met in β-cell proliferation in situations of reduced β-cell mass. Indeed, adult PancMet KO mice displayed markedly reduced β-cell replication compared with WT mice 7 days post-Ppx. Similarly, β-cell proliferation was decreased in PancMet KO mice in the MLDS mouse model. The decrease in β-cell proliferation post-Ppx correlated with a striking decrease in D-cyclin levels. Importantly, PancMet KO mice showed significantly diminished β-cell mass, decreased glucose tolerance, and impaired insulin secretion compared with WT mice 28 days post-Ppx. Conversely, HGF administration in WT Ppx mice further accelerated β-cell regeneration. These results indicate that HGF/c-Met signaling is critical for β-cell proliferation in situations of diminished β-cell mass and suggest that activation of this pathway can enhance β-cell regeneration.

1 May 2023 in Genome Medicine
Verified
Journal Article
Open access
PDF file
RKRandy B. Kang
Randy B. Kang
YLYansui Li
Yansui Li
CRCarolina Rosselot
Carolina Rosselot
TZTuo Zhang
Tuo Zhang
MSMustafa Siddiq
Mustafa Siddiq
GLGeming Lu
Geming Lu
Background: Single-cell RNA sequencing (scRNA-seq) provides valuable insights into human islet cell types and their corresponding stable gene expression profiles. However, this approach requires cell dissociation that complicates its utility in vivo. On the other hand, single-nucleus RNA sequencing (snRNA-seq) has compatibility with frozen samples, elimination of dissociation-induced transcriptional stress responses, and affords enhanced information from intronic sequences that can be leveraged to identify pre-mRNA transcripts. Methods: We obtained nuclear preparations from fresh human islet cells and generated snRNA-seq datasets. We compared these datasets to scRNA-seq output obtained from human islet cells from the same donor. We employed snRNA-seq to obtain the transcriptomic profile of human islets engrafted in immunodeficient mice. In both analyses, we included the intronic reads in the snRNA-seq data with the GRCh38-2020-A library. Results: First, snRNA-seq analysis shows that the top four differentially and selectively expressed genes in human islet endocrine cells in vitro and in vivo are not the canonical genes but a new set of non-canonical gene markers including ZNF385D, TRPM3, LRFN2, PLUT (β-cells); PTPRT, FAP, PDK4, LOXL4 (α-cells); LRFN5, ADARB2, ERBB4, KCNT2 (δ-cells); and CACNA2D3, THSD7A, CNTNAP5, RBFOX3 (γ-cells). Second, by integrating information from scRNA-seq and snRNA-seq of human islet cells, we distinguish three β-cell sub-clusters: an INS pre-mRNA cluster (β3), an intermediate INS mRNA cluster (β2), and an INS mRNA-rich cluster (β1). These display distinct gene expression patterns representing different biological dynamic states both in vitro and in vivo. Interestingly, the INS mRNA-rich cluster (β1) becomes the predominant sub-cluster in vivo. Conclusions: In summary, snRNA-seq and pre-mRNA analysis of human islet cells can accurately identify human islet cell populations, subpopulations, and their dynamic transcriptome profile in vivo.

19 February 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KKKunal Kumar
Kunal Kumar
PWPeng Wang
Peng Wang
JWJessica Wilson
Jessica Wilson
VZViktor Zlatanic
Viktor Zlatanic
CBCecilia Berrouet
Cecilia Berrouet
RDRobert J. DeVita
Robert J. DeVita